Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Autologous Cell-Based Therapy for Hyperglycemia in Type 2 Diabetes
NCT02169531Phase 1Completed
- Sponsor
- B & Y Technologies
- Start
- Mar 2014
- Primary completion
- Jun 2015
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in type 2 diabetes mellitus (T2DM), sponsored by B & Y Technologies. Primary endpoint: Change from Baseline Hemoglobin A1c at 27 weeks. Started Mar 2014; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02169531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02169531.